Drug Type Synthetic peptide |
Synonyms B720389K560, DLS-10, NSC-376128 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC42H68N6O6S |
InChIKeyOFDNQWIFNXBECV-VFSYNPLYSA-N |
CAS Registry110417-88-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Soft Tissue Sarcoma | Phase 2 | United States | 01 Apr 1999 | |
Ovarian Cancer | Phase 2 | United States | 01 Apr 1999 | |
Recurrent Sarcoma | Phase 2 | United States | 01 Apr 1999 | |
Carcinoma of extrahepatic bile duct | Phase 2 | United States | 01 Jan 1999 | |
Hepatobiliary cancer | Phase 2 | United States | 01 Jan 1999 | |
Liver Cancer | Phase 2 | United States | 01 Jan 1999 | |
Metastatic gallbladder cancer | Phase 2 | United States | 01 Jan 1999 |
Phase 2 | 16 | yevnmffnkd(rusaslfuvb) = yccuxhobyd sylmbfxuem (ygqxlgnwin ) | Negative | 01 Nov 2000 |